These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 19841316)

  • 21. Acute promyelocytic leukemia with amplification of PML-RARalpha rearrangement: clinical implications.
    Luatti S; Marzocchi G; Ottaviani E; Baldazzi C; Stacchini M; Gamberini C; Salmi F; Martinelli G; Baccarani M; Testoni N
    Leuk Res; 2008 Dec; 32(12):1941-3. PubMed ID: 18468683
    [No Abstract]   [Full Text] [Related]  

  • 22. Acute promyelocytic leukemia: new issues on pathogenesis and treatment response.
    Vitoux D; Nasr R; de The H
    Int J Biochem Cell Biol; 2007; 39(6):1063-70. PubMed ID: 17468032
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The relationship between clinical prognosis and classification of the isoforms of fuse gene in acute promyelocytic leukemia].
    Liu J; Qi ZH; Cao P
    Hunan Yi Ke Da Xue Xue Bao; 2000 Dec; 25(6):564-6. PubMed ID: 12516405
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acute promyelocytic leukemia: a view from a mouse.
    Kogan SC
    Blood Cells Mol Dis; 2000 Dec; 26(6):620-5. PubMed ID: 11358354
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The APL-associated fusion proteins.
    Minucci S; Cioce M; Maccarana M; Pelicci PG
    Haematologica; 1999 Jun; 84 Suppl EHA-4():70-1. PubMed ID: 10907473
    [No Abstract]   [Full Text] [Related]  

  • 26. [Detection of the PML/RAR alpha rearrangement in acute promyelocytic leukemia using a reverse PCR method].
    Barragán E; Bonanad S; López JA; Martín G; Martínez J; Sanz GF; Gomis F; Pérez ML; Senent ML; Larrea L; Bolufer P; Sanz MA
    Sangre (Barc); 1996 Jun; 41(3):189-94. PubMed ID: 8755206
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acute promyelocytic leukemia harboring a STAT5B-RARA fusion gene and a G596V missense mutation in the STAT5B SH2 domain of the STAT5B-RARA.
    Iwanaga E; Nakamura M; Nanri T; Kawakita T; Horikawa K; Mitsuya H; Asou N
    Eur J Haematol; 2009 Nov; 83(5):499-501. PubMed ID: 19624718
    [No Abstract]   [Full Text] [Related]  

  • 28. PML/RARalpha, a fusion protein in acute promyelocytic leukemia, prevents growth factor withdrawal-induced apoptosis in TF-1 cells.
    Fu S; Consoli U; Hanania EG; Zu Z; Claxton DF; Andreeff M; Deisseroth AB
    Clin Cancer Res; 1995 Jun; 1(6):583-90. PubMed ID: 9816019
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Residual disease in AML, a target that can move in more than one direction.
    Loken MR
    Cytometry B Clin Cytom; 2014 Jan; 86(1):15-7. PubMed ID: 24243851
    [No Abstract]   [Full Text] [Related]  

  • 30. Specificity of immunophenotyping in acute promyelocytic leukemia.
    Oelschlägel U; Nowak R; Mohr B; Thiede C; Ehninger G; Schaub A; Köppel C; Herbst R
    Cytometry; 2000 Dec; 42(6):396-7. PubMed ID: 11135296
    [No Abstract]   [Full Text] [Related]  

  • 31. Occurrence of BCR/ABL fusion gene in a patient with acute promyelocytic leukemia.
    Zhang LJ; Gan YM; Yu L
    Med Oncol; 2015 Jan; 32(1):382. PubMed ID: 25428388
    [No Abstract]   [Full Text] [Related]  

  • 32. [Relapse of acute promyelocytic leukemia in the external auditory canal of a patient].
    Yang XQ; Yu LS
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2007 Aug; 42(8):628-9. PubMed ID: 17944219
    [No Abstract]   [Full Text] [Related]  

  • 33. Genomic analysis of the clonal origin and evolution of acute promyelocytic leukemia in a unique patient with a very late (17 years) relapse.
    Zhang X; Zhang Q; Dahlström J; Tran AN; Yang B; Gu Z; Ghaderi M; Porwit A; Jia J; Derolf A; Xu D; Björkholm M
    Leukemia; 2014 Aug; 28(8):1751-4. PubMed ID: 24651096
    [No Abstract]   [Full Text] [Related]  

  • 34. Histiocytic clearance of neoplastic cells in acute promyelocytic leukemia.
    Schafernak KT; Corey SJ
    Blood; 2014 Nov; 124(19):3020. PubMed ID: 25539010
    [No Abstract]   [Full Text] [Related]  

  • 35. Management of relapsed and refractory childhood acute promyelocytic leukaemia: recommendations from an international expert panel.
    Abla O; Kutny MA; Testi AM; Feusner JH; Creutzig U; Gregory J; Gibson B; Leverger G; Ribeiro RC; Smith O; Locatelli F; Kaspers G
    Br J Haematol; 2016 Nov; 175(4):588-601. PubMed ID: 27651168
    [No Abstract]   [Full Text] [Related]  

  • 36. A pediatric case of acute megakaryocytic leukemia with double chimeric transcripts of CBFA2T3-GLIS2 and DHH-RHEBL1.
    Mitsui-Sekinaka K; Sekinaka Y; Ogura Y; Honda M; Ohyama R; Oyama C; Isobe K; Mori M; Arakawa Y; Koh K; Hanada R; Nonoyama S; Kawaguchi H
    Leuk Lymphoma; 2018 Jun; 59(6):1511-1513. PubMed ID: 29043865
    [No Abstract]   [Full Text] [Related]  

  • 37. Vaccine hope for acute promyelocytic leukaemia.
    Ahmad K
    Lancet Oncol; 2003 Dec; 4(12):712. PubMed ID: 14682344
    [No Abstract]   [Full Text] [Related]  

  • 38. Central nervous system relapse of acute promyelocytic leukaemia in a patient with cerebral haemorrhage at diagnosis.
    Macheta MP; Shun JK; Yin JA
    Br J Haematol; 2001 Sep; 114(4):954-5. PubMed ID: 11564092
    [No Abstract]   [Full Text] [Related]  

  • 39. Auer on the top!
    Hazarika B
    Blood; 2013 Nov; 122(22):3558. PubMed ID: 24400361
    [No Abstract]   [Full Text] [Related]  

  • 40. "It's effective therapy, stupid!".
    Ravandi F
    Leuk Res; 2013 Nov; 37(11):1434-5. PubMed ID: 24045028
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.